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ABSTRACT
BACKGROUND: Carpal tunnel syndrome (CTS) is caused by the compression of median nerve in carpal tunnel. Carpal
bones make the floor of the carpal tunnel and the transverse carpal ligament forms the roof. Components include
median nerve and the flexor tendons. The pain may be localized to the wrist or may radiate to forearm, arm or rarely
shoulder. Effectiveness of treatment by intracarpal corticosteroid injection in comparison with NSAID has never been
investigated. The objective of this study was to determine if corticosteroid injections for carpal tunnel syndrome are
effective compared to NSAID.
METHODS: In this study 46 participants with a clinical diagnosis of CTS were recruited. Participants were randomly
assigned treatment group A (intra carpal tunnel steroid injection) and B (NSAID) by coin flipping method. Main
outcomes, mean score of the Symptom Severity Scale (SSS) of the Boston carpal tunnel questionnaire, subjective
improvement during follow-up were collected. Duration of follow-up was 3 months.
RESULTS: The median duration of symptoms was 8 months in NSAID group and 7 months in Steroid group post
treatment. Steroid group showed better direct treatment response (P=0.001) and perceived improvement (P=0.001)
than the NSAID group in the outcomes. Symptom severity score improved significantly after steroid treatment
compared to NSAID group, from (2.79 to 1.01) in steroid group versus (2.58 to 2.45) in NSAID group
CONCLUSION: Intracarpal tunnel steroids injection was more effective as compared to NSAID in management of
carpal tunnel syndrome.
Key words: Carpal tunnel syndrome, steroids, NSAIDs

INTRODUCTION
Carpal tunnel syndrome (CTS) is caused by the
compression of median nerve in carpal tunnel. Carpal
bones make the floor of the carpal tunnel and the
transverse carpal ligament forms the roof. Components
include median nerve and the flexor tendons. The pain
may be localized to the wrist or may radiate to forearm,
arm or rarely shoulder. Paresthesias are frequently
present in medial thumb, index, middle and lateral ring
finger. During sleep, paresthesias worsen due to
increase in carpal tunnel pressure and nerve ischemia.
The annual incidence of CTS is 0.1% among adults and
prevalence is 2.7% in general population.(1,2) It
frequently affects female more than male, literature
review on demographic characteristics of CTS in
Pakistan population revealed a ratio of 4.8:1 which is
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near to ratio of 5.6:1 in a study done by Gomes in
Brazil, reason being female population have small
carpal tunnels compared to males.(1,3) Etiology is likely
related to occupations involving excessive use of hand
or wrist like in typists, mechanics, carpenters. An
interesting study done on prevalence of CTS in dentists
working in Karachi, revealed prevalence of 10.31% (4)
Similar literature on association of CTS with the specific
occupation can be found in laboratory workers in India
with the prevalence of 21.5% and in Saudi Arabia it
was 25.3% (5,6) This high prevalence reflects significant
association of CTS with the occupation. Risk factors of
CTS include diabetes, obesity, age, pregnancy,
hypothyroidism, rheumatoid arthritis, gout, acromegaly,
amyloidosis, arterio-venous shunts for hemodialysis

21

V O L . 1 6 ( 1 ) J A N U A R Y- M A R C H 2 0 2 1

O R I G I N A L

A R T I C L E

and fractures at the wrist. Diagnosis of CTS can be
made clinically and confirmed by American Academy of
Neurology (AAN) electro diagnostic criteria. (11) On
examination sensory changes like impaired pin-prick
and two point discrimination in the distribution of
median nerve can be elicited. Symptoms can be
reproduced by Phalen maneuver (7,8) (flexion at both
wrists for 1 minute) and Reverse Phalen maneuver
(hyperextension of the wrist). Percussion at the wrist
causes paresthesias in the distribution of median nerve
suggestive of positive Tinel’s sign is also a specific
clinical sign of CTS. In severe cases patients develop
muscle weakness and atrophy(9,10). Treatment of CTS
includes oral analgesics, NSAIDS, wrist splinting,
intra-carpal tunnel steroid injections or tendon release
surgery. NSAIDs provide anti-inflammatory effects and
reduces edema in carpal tunnel leading to relieve of
symptoms. Though literature search showed limited
benefit with NSAIDs in the management of CTS but
NSAIDs still are considered first line for conservative
management (12).

• 3 = complete resolution of symptoms and signs
2. Improvement as perceived by patient:
• -2 = much worse
• -1 = worse
• 0 = not better/not worse
• + 1 = better
• + 2 = much better

METHODS:

At the significance level of 5%, power of the study 80%,
percentage success in control NSAID group 50% and
percentage success in experimental steroid group as
86% (10), the sample size from sealed envelope was
calculated to be 23 per group and total 46

Symptom severity was assessed by using the Symptom
Severity Scale (SSS), which is the part of Boston Carpal
Tunnel Questionnaire (BCTQ). The BCTQ is a
patient-reported outcome measure for CTS and has
been tested for validity, reliability and responsiveness.
The SSS has 11 questions- use a five-point scale. Each
scale generates a final score (sum of individual item
scores divided by number of items), which ranges from
1 to 5. Higher SSS correlate with more severe
symptoms.
Follow up measurements were performed by sending
questionnaires to participants 1, 3 months.
Sample size and data analysis:

Setting: Patients were recruited from the outpatient
department of Ziauddin university hospital
Patient
criteria:

recruitment

and

inclusion/exclusion

RESULTS:

Patients presenting with symptoms and signs
suggestive of carpal tunnel syndrome were eligible for
inclusion. Exclusion criteria were thenar atrophy, being
less than 18 years of age, presence of
contraindications
for
corticosteroid
injection
(hypersensitivity to corticosteroids, local skin infection),
prior treatment for CTS in the last six months with
steroid injection or surgery, traumatic or neoplastic
origin of symptoms, co-existing diseases such as
polyneuropathy, cervical radiculopathy and thoracic
outlet syndrome, inability to fill in follow-up forms or
absence of self-determination in the participant. After
applying in- and exclusion criteria, written informed
consent was obtained from participants by their general
practitioner.

Characteristics

Age in years

Intervention

P-value

Nsaid
23(50)

Steroid
23(50)

Duration of symptoms

38.35±11.9
7
8.30±3.83

36.78±12.1
2
8.86±4.07

39.9±11.8
7
7.73±3.58

Gender
Male
Female

16(34.8)
30(65.2)

8(34.8)
15(65.2)

8 (34.8)
15(65.2)

Symptoms
Pain
Paesthesias
Tingling
Numbness

17(37)
17(37)
8(17.4)
4(8.7)

4(17.4)
12(52.2)
5(21.7)
2(8.7)

13(56.5)
5(21.7)
3(13)
2(8.7)

Positive
Negative

43(93.5)
3(6.5)

20(87)
3(13)

23(100)
0(0)

Tinel Test
Positive
Negative

43(93.5)
3(6.5)

20(87)
3(13)

23(100)
0(0)

Symptom severity score
Mean score at baseline

2.69±0.36

2.58±0.39

2.79±0.30

0.054**

Mean score after 1 month

1.73±0.76

2.45±0.31

1.01±0.03

<0.001*

Mean score after 3 month

1.72±0.76

2.45±0.31

1.00±0.02

<0.001*

No response
Partial response but not satisfactory, warranting
further treatment
Partial response but satisfactory, not warranting
further treatment
Complete resolution of symptoms and signs
Improvement as percieved by patient at 1 month

6(13)
17(37)

6(26.1)
17(73.9)

0(0)
0(0)

6(13)

0(0)

6(26.1)

17(37)

0(0)

17(73.9)

Not better/not worse
Better
Much better

22(47.8)
7(15.2)
17(37)

22(95.7)
1(4.3)
0(0)

0(0)
6(26.1)
17(73.9)

2(4.3)
21(45.7)

2(8.7)
21(91.3)

0(0)
0(0)

4(8.7)

0(0)

4(17.4)

19(41.3)

0(0)

19(82.6)

22(47.8)
5(10.9)
19(41.3)

22(95.7)
1(4.3)
0(0)

0(0)
4(17.4)
19(82.6)

0.233**

0.233**

<0.001*

<0.001*

Direct Treatment Response at 3 month
No response
Partial response but not satisfactory, warranting
further treatment
Partial response but satisfactory, not warranting
further treatment
Complete resolution of symptoms and signs

<0.001*

Improvement as percieved by patient at 3 month
Not better/not worse
Better
Much better

22

0.332**

0.038*

Direct Treatment Response at 1 month

Through flip coin method
Outcome measurement:
1. Direct treatment response (based on consensus
between physician and patient):
• 0 = no response
• 1 = partial response, but not satisfactory, warranting
further treatment
• 2 = partial response, satisfactory, not warranting
further treatment

0.381**

1.000**

Phalen Test

Randomization:
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Summary amain findings:

treatment groups had comparable severity of CTS at
baseline. Eighty wrists were randomly assigned to the
surgery group and 83 wrists to the local steroid
injection group. In the intent-to-treat analysis, at 3
months of follow-up, 94.0% of the wrists in the steroid
injection group versus 75.0% in the surgery group
reached a 20% response for nocturnal paresthesias (P
= 0.001). At 6 and 12 months, the percentages of
responders were 85.5% versus 76.3% (P = 0.163)
and 69.9% versus 75.0% (P = 0.488), for local steroid
injection and surgical decompression, respectively.
Over the short term, local steroid injection is better than
surgical decompression for the symptomatic relief of
CTS. At 1 year, local steroid injection is as effective as
surgical decompression for the symptomatic relief of
CTS. Gurcay et al conducted a randomised clinical trial
in patients with CTS, assessing functional findings and
electrophysiologic examinations on initial visit and at
the third month, comparing treatment either with
NSAID or local steroid injection. The results showed
that neither of the groups demonstrated superior
efficacy. (23) These were contrary to our results.

The median duration of symptoms was 8 months in
NSAID group and 7 months in Steroid group. Steroid
group showed better direct treatment response
(P=0.001) and perceived improvement (P=0.001)
than the NSAID group in the outcomes. Symptom
severity score improved significantly after steroid
treatment compared to NSAID group. From (2.79 to
1.01) in steroid group versus (2.58 to 2.45) in NSAID
group
Comparison with existing literature:
As far as isolated effect of Local steroid injections was
concerned literature revealed that they have been
proved effective for treating carpal tunnel syndrome.
Patient satisfaction, clinical improvement , symptoms,
function and pain were shown to improve after
cortisone injections.(13-19) Similar to our study where we
have proven superiority of steroid injections. Cochrane
database systemic review showed that local
corticosteroid injection for carpal tunnel syndrome
provides greater clinical improvement in symptoms one
month after injection compared to placebo. They also
added that steroid injection provides significantly
greater clinical improvement than oral steroid for up to
three months. Two local corticosteroid injections do not
provide significant added clinical benefit compared to
one injection. (20, 21) Another trial which is part of a larger
study called the Groningen Hand and Wrist Injection
Therapy Trial (HAWITT) evaluated the efficacy and
feasibility of steroid injections for carpal tunnel
syndrome, de Quervain's tenosynovitis and trigger finger
in primary care. The results of this study suggest that
intra-carpal
tunnel
injection
with
1
ml
triamcinolonacetonide 10 mg/ml are effective with
respect to short-term outcomes when compared to
placebo-injections in patients presenting to their
general practitioner with a clinical diagnosis of CTS.
Long-term effectiveness is less clear: the achieved
treatment effects seem to diminish slowly in half of the
cohort of patients that responded to steroid injections
during the 12 months after the intervention and
recurrences occurred in the other half of the cohort of
steroid responders. When comparing the effectiveness
of local steroid injection and carpal tunnel release
operation for the treatment of CTS, local steroid
injections give transient relief where as carpal tunnel
release surgery provides long-lasting relief as shown in
a short series of 40 patients with short-term follow-up
of 12 weeks (22) Optimal treatment of CTS has not been
established.This study compared the effects of local
steroid injection versus surgical decompression in
new-onset CTS of at least 3 months' duration. Both
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Strength and limitations:
To our knowledge this is the first randomized clinical
trial comparing efficacy of steroids with NSAID. Strong
points in our study were that randomization was
rigorous, we used valid patient assessment tool. Our
trial did not include nerve conduction study because
our study dependent on the clinical signs and
symptoms of CTS. Due to small sample size our study
cannot be generalizable for the population of patients
presenting with CTS.
Conclusion
In our opinion steroid injection into the carpal tunnel is
a safe, easy to learn and apply therapeutic intervention
and it is superior in efficacy compared to NSAID. We
feel that initial treatment of patients with CTS should be
intra carpal tunnel steroid injections.
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